Some Canadian pharmacists are already stocking their shelves with generic versions of semaglutide, more commonly known by the ...

People with type 2 diabetes who are taking a GLP-1 now have a newly branded option for treatment. Novo Nordisk, which makes the GLP-1 semaglutide medications Ozempic and Wegovy, announced that it’s ...

TORONTO — Two generic versions of Ozempic are set to start arriving in Canadian pharmacies this week, which means patients who use the drug to treat diabetes or for weight loss may have more options ...

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs don’t work the same for everyone.

When you stop taking the miracle weight-loss drug, the cravings return—for food, yes, but also for something more.

Semaglutide is an injectable drug formulated for the treatment of type 2 diabetes, but it’s since become increasingly popular ...

Add Yahoo as a preferred source to see more of our stories on Google. When we talk about GLP-1 medications, we’re usually focused on weight loss or the drug’s side effects (we’re looking at you, ...

This article was reviewed by Lynn Marie Morski, MD, JD. You may have heard about — or maybe even experienced — the short-term side effects of Ozempic — such as nausea, vomiting, constipation, and ...

Ozempic and similar GLP-1 medications are basically miracle drugs when it comes to insulin control and weight loss, but it ...

Ladies and gentlemen, the moment has arrived: generic versions of the miracle weight-loss drug semaglutide, best known under its corporate trade names of Ozempic and Wegovy, are now beginning to ...

Generic versions of Ozempic, a Type 2 diabetes medication widely prescribed off-label for weight loss, are expected to pop up ...

Thursday the availability of generic semaglutide through its platform, allowing eligible Canadians access to digital ...